Documente Academic
Documente Profesional
Documente Cultură
USP <61> Acceptance criteria for nonsterile pharmaceutical substances per dosage forms per USP <1111> USP <62> Acceptance criteria for nonsterile pharmaceutical substances per dosage forms per USP <1111>
Route of Admission
Test Code
Description
MEP100
The validation and suitability testing are performed once for each product. The testing verifies the validity of the testing method by demonstrating any antimicrobial properties of the product do not inhibit possible recovery of growth. Total Aerobic Microbial Counts: 1000 CFU/g or CFU/mL The USP <61> and <62> tests are designed to validate and determine the quantitation of organisms present and screen for the presence or absence of objectionable organisms.
MEP205 Total Yeasts and Molds Counts: 100 CFU/g or CFU/mL Total Aerobic Microbial Counts: 100 CFU/g or CFU/mL
MEP205 Total Yeasts and Molds Counts: 100 CFU/g or CFU/mL Total Aerobic Microbial Counts: 100 CFU/g or CFU/mL
The USP <61> and <62> tests are designed to validate and determine the quantitation of organisms present and screen for the presence or absence of objectionable organisms.
Inhalation Use
MEP210 Total Yeasts and Molds Counts: 10 CFU/g or CFU/mL Total Aerobic Microbial Counts: 100 CFU/g or CFU/mL
Absence of Staphylococcus aureus, Pseudomonas aeruginosa, and biletolerant Gram-negative bacteria in 1 gram/mL Absence of Staphylococcus aureus and Pseudomonas aeruginosa in 1 patch
The USP <61> and <62> tests are designed to validate and determine the quantitation of organisms present and screen for the presence or absence of objectionable organisms.
Transdermal Patches
MEP215
The USP <61> and <62> tests are designed to validate and determine the quantitation of organisms present and screen for the presence or absence of objectionable organisms.
Total Yeasts and Molds Counts: 10 CFU/g or CFU/mL Total Aerobic Microbial Counts: 1000 CFU/g or CFU/mL
Rectal Use
MEP220 Total Yeasts and Molds Counts: 100 CFU/g or CFU/mL Total Aerobic Microbial Counts: 100 CFU/g or CFU/mL
N/A
The USP <61> test is designed to validate and determine the quantitation of organisms present. The USP <61> and <62> tests are designed to validate and determine the quantitation of organisms present and screen for the presence or absence of objectionable organisms.
Vaginal Use
MEP225 Total Yeasts and Molds Counts: 10 CFU/g or CFU/mL Total Aerobic Microbial Counts: 100 CFU/g or CFU/mL MEP230 Total Yeasts and Molds Counts: 10 CFU/g or CFU/mL
The USP <61> and <62> tests are designed to validate and determine the quantitation of organisms present and screen for the presence or absence of objectionable organisms.
P.O. Box 571830 | Murray, UT 84157-1830 6280 S Redwood Road | Salt Lake City, UT 841236600 www.nelsonlabs.com Telephone 801 290 7500 Fax 801 290 7998 sales@nelsonlabs.com
<62>
Test code
Organisms All 7 organisms: Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, bile-tolerant Gram-negative bacteria, Clostridia, Salmonella and Candida albicans Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, bile-tolerant Gram-negative bacteria, Clostridia, Salmonella and/or Candida albicans Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, bile-tolerant Gram-negative bacteria, Clostridia, Salmonella and/or Candida albicans
Description The USP <62> suitability testing is performed once for each product. The testing verifies the validity of the testing method by demonstrating any antimicrobial properties of the product do not inhibit possible recovery of growth during the test for specified microorganisms. The suitability test demonstratives recovery of Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, bile-tolerant Gram-negative bacteria, Clostridia, Salmonella and Candida albicans The USP <62> suitability testing is performed once for each product. The testing verifies the validity of the testing method by demonstrating any antimicrobial properties of the product do not inhibit possible recovery of growth during the test for specified microorganisms. The suitability test demonstratives recovery of Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, bile-tolerant Gram-negative bacteria, Clostridia, Salmonella and/or Candida albicans
MEP105
Suitability <62>
MEP110
MEP235
The USP <62> routine the test for specified microorganisms; Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, bile-tolerant Gram-negative bacteria, Clostridia, Salmonella and/or Candida albicans
<61>
Test Code
Description The USP <61> plate count validation testing is performed once for each product. The testing verifies the validity of the testing method by demonstrating any antimicrobial properties of the product do not inhibit possible recovery of growth during the total aerobic microbial and total yeasts and molds counts.
Validation <61>
MEP115
MEP250
USP <61> testing to determine the total aerobic microbial and total yeasts and molds counts performed with the membrane filtration method.
MEP255
USP <61> testing to determine the total aerobic microbial and total yeasts and molds counts performed with the pour plate method.
MEP260
USP <61> testing to determine the total aerobic microbial and total yeasts and molds counts performed with the surface spread method.
MEP265
USP <61> testing to determine the total aerobic microbial counts or total yeasts and molds counts testing.
P.O. Box 571830 | Murray, UT 84157-1830 6280 S Redwood Road | Salt Lake City, UT 841236600 www.nelsonlabs.com Telephone 801 290 7500 Fax 801 290 7998 sales@nelsonlabs.com